Impact of Treatment Adherence on Efficacy of Dolutegravir + Lamivudine and Dolutegravir + Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Week 144 Analysis of the GEMINI-1 and GEMINI-2 Clinical Studies

Author:

Fernvik Eva1,Sierra Madero Juan2,Espinosa Nuria3,Gulminetti Roberto4,Hagins Debbie5,Tsai Hung-Chin67,Man Choy8,Sievers Jörg9,Grove Richard10,Zolopa Andrew811,Wynne Brian8,van Wyk Jean9,Ait-Khaled Mounir9

Affiliation:

1. ViiV Healthcare, Stockholm, Sweden;

2. Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico;

3. Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBiS), Sevilla, Spain;

4. Fondazione IRCCS Policlinico S. Matteo, Infectious Diseases, University of Pavia, Pavia, Italy;

5. Georgia Department of Public Health, Coastal Health District, Chatham CARE Center, Savannah, GA;

6. Department of Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan;

7. National Yang Ming Chiao Tung University, Taipei, Taiwan;

8. ViiV Healthcare, Durham, NC;

9. ViiV Healthcare, Brentford, UK;

10. GSK, Brentford, UK; and

11. Stanford University, Palo Alto, CA.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3